scorecardresearch
Follow Us:
Saturday, May 28, 2022

Covid-19: Painkiller Ibuprofen tested as potential treatment in London

Half of the 230 COVID-19 patients participating in the trial were given a special formulation of Ibuprofen, distinct from the over-the-counter variant sold across the world.

By: Express Web Desk | New Delhi |
Updated: June 3, 2020 7:05:51 pm
covid-19 treatment, Painkiller Ibuprofen, london, coronavirus outbreak, united kingdom, covid-19 vaccine, world news, indian express The trial, called Liberate, was launched after studies conducted on animals suggested that the medication could treat acute respiratory distress syndrome — one of the complications associated with COVID-19. (Representational)

A team of researchers from London’s Guy’s and St Thomas’ hospital and King’s College are running a trial to see whether painkiller and anti-inflammatory medication Ibuprofen can be used to treat COVID-19 patients, BBC reported. As the world struggles to contain the impact of the global pandemic, scientists hope that the low-cost treatment will reduce the burden on hospitals by keeping patients off ventilators.

The trial, called Liberate, was launched after studies conducted on animals suggested that the medication could treat acute respiratory distress syndrome — one of the complications associated with COVID-19.

Half of the 230 patients participating in the trial were given a special formulation of Ibuprofen — distinct from the over-the-counter drug available at most pharmacies, according to the BBC report. The other half will receive standard care, which includes continuously being given oxygen.

Professor Mitul Mehta, a member of the research team, stressed that the trial was for hospitalised patients and not for mild cases. Participants were drawn from among those hospitalised, but not requiring intensive care, according to the BBC.

Best of Express Premium

‘Monetisation’ axed, MeitY’s fresh draft to ‘encourage’ cos to share non-...Premium
Supreme Court directions on sex workers: history of the case, and where i...Premium
Cruise drug raid case: One officer went rogue, agency looked other wayPremium
Hindus and Muslims must give up rigid positions on contested places of wo...Premium

At the onset of the pandemic in the United Kingdom, health experts had raised concerns over whether the anti-inflammatory should be used by people showing mild symptoms. Following this, the UK’s National Health Service (NHS) in March withdrew the advisory they had issued on their website for the use of ibuprofen by people suffering from mild cases of COVID-19.

With over 279,392 Covid-19 cases and 39,452 registered deaths, the UK is one of the worst-hit countries in the world. Lockdown restrictions, imposed by Prime Minister Boris Johnson in March, are now gradually being relaxed.

For all the latest World News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement